Boeckler C, Dautel D, Schelté P, Frisch B, Wachsmann D, Klein J P, Schuber F
Laboratoire de Chimie Bioorganique, Université Louis Pasteur, Faculté de Pharmacie, Strasbourg-Illkirch, France.
Eur J Immunol. 1999 Jul;29(7):2297-308. doi: 10.1002/(SICI)1521-4141(199907)29:07<2297::AID-IMMU2297>3.0.CO;2-5.
We have designed liposomal diepitope constructs that allow the physical combination, within the same vesicle, of B and Th epitopes as structurally separate entities. The immune response against such constructs was explored using TPEDPTDPTDPQDPSS (TPE), a B cell epitope originating from a Streptococcus mutans surface adhesin and QYIKANSKFIGITEL (QYI), a "universal" Th epitope from tetanus toxin. The two peptides were linked to the outer surface of small (diameter approximately 100 nm) unilamellar liposomes by covalent conjugation to two different anchors. To that end we have developed a strategy that allows the controlled chemical coupling of TPE and QYI, functionalized at their N terminus with a thiol, to preformed liposomes containing thiol-reactive derivatives of phosphatidylethanolamine and the lipopeptide S-[2,3-bis (palmitoyloxy)-(2-RS)-propyl]-N-palmitoyl-(R)-cysteinyl-alanyl-gly cine (Pam3CAG), respectively. This synthetic construct (administered i.p. to BALB/c mice) induced highly intense (titers > 20,000), anamnestic and long-lasting (over 2 years) immune responses, indicating that this strategy is successful. Two parameters were of prime importance to elicit this response with our liposomal diepitope constructs: (1) the simultaneous expression of B and Th epitopes on the same vesicle, and (2) the lipopeptide Pam3CAG anchor of the Th epitope QYI could not be replaced by a phosphatidylethanolamine anchor (a lesser immune response was observed). Analysis of the antibody response revealed a complex pattern; thus, besides the humoral response (production of IgG1, IgG2a, IgG2b) a superposition of a T-independent (TI-2 type) response was also found (IgM and IgG3). These results indicate that liposomal diepitope constructs could be attractive in the development of synthetic peptide-based vaccines.
我们设计了脂质体双表位构建体,使B细胞表位和Th细胞表位能在同一囊泡内以结构上分离的实体形式进行物理组合。我们使用源自变形链球菌表面粘附素的B细胞表位TPEDPTDPTDPQDPSS(TPE)和破伤风毒素的“通用”Th细胞表位QYIKANSKFIGITEL(QYI),来探究针对此类构建体的免疫反应。通过与两种不同的锚定物共价偶联,将这两种肽连接到小的(直径约100 nm)单层脂质体的外表面。为此,我们开发了一种策略,可将在N端用硫醇功能化的TPE和QYI与预先形成的脂质体进行可控化学偶联,所述脂质体分别含有磷脂酰乙醇胺的硫醇反应性衍生物和脂肽S-[2,3-双(棕榈酰氧基)-(2-RS)-丙基]-N-棕榈酰-(R)-半胱氨酰-丙氨酰-甘氨酸(Pam3CAG)。这种合成构建体(腹腔注射给BALB/c小鼠)诱导出高强度(滴度>20,000)、记忆性和持久(超过2年)的免疫反应,表明该策略是成功的。对于我们的脂质体双表位构建体,有两个参数对于引发这种反应至关重要:(1)同一囊泡上B细胞表位和Th细胞表位的同时表达,以及(2)Th细胞表位QYI的脂肽Pam3CAG锚定物不能被磷脂酰乙醇胺锚定物替代(观察到免疫反应较弱)。对抗体反应的分析揭示了一种复杂模式;因此,除了体液反应(产生IgG1、IgG2a、IgG2b)外,还发现了非T细胞依赖性(TI-2型)反应的叠加(IgM和IgG3)。这些结果表明,脂质体双表位构建体在基于合成肽的疫苗开发中可能具有吸引力。